AsiaOne
Amgen's rare disease drug linked to deaths, liver injuries in Japan
About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease drug Tavneos, according to a safety notice issued by partner Kissei ...
Amgen drug gets new warnings in Japan after patient deaths
The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
Hosted on MSN
Amgen’s Tavneos reportedly linked to 20 deaths in Japan
Twenty people died in Japan after receiving Tavneos, a rare disorder therapy developed by Amgen (AMGN), prompting its local partner Kissei (KSPHF) to urge healthcare professionals to exercise caution ...
20 People in Japan Died After Taking Amgen Drug
Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new patients.
Japan drugmaker urges doctors not to use kidney disease med Tavneos for new patients
Japan's Kissei Pharmaceutical Co. has started urging doctors to refrain from using Tavneos, a drug used to treat rare kidney diseases ...
Los Angeles Business Journal
Amgen Drug Reviewed Amid Deaths
Sales of the problematic Amgen Inc. drug Tavneos resumed late last week in Japan with a new warning label after several patient deaths potentially linked ...
Medical Xpress
Japan pharmaceutical firm warns against rare diseases drug after deaths
A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients following the deaths of 20 people who took it. Kissei Pharmaceutical, which ...
Kissei Revises Package Insert in Japan for Amgen's Tavneos
Kissei Pharmaceutical has revised a package insert in Japan for Amgen's rare immune-disease drug Tavneos, saying that serious liver dysfunction could occur. The Japanese pharmaceutical company said ...
Amgen Reevaluates Tavneos Data as Medicine Faces FDA Scrutiny
Amgen Inc. has engaged an independent academic organization to reevaluate data for a rare disease drug that US regulators are ...
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports
About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with ​Amgen's rare disease drug Tavneos, according to a safety notice ‌issued by partner Kissei ...
Wall Street Journal
Amgen Drug Gets New Warnings in Japan After Patient Deaths
Japanese drugmaker Kissei Pharmaceutical 4547-3.37%decrease; red down pointing triangle said doctors in Japan can again prescribe an Amgen AMGN 0.12%increase; green up pointing triangle rare-disease ...
Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports
At ‌least 20 ‌people in ​Japan who took Amgen's rare ‌disease ⁠drug have died, ⁠while 22 ​others ​developed ​potentially fatal ‌liver injuries, the Wall Street Journal ‌reported ​on ​Friday, ​citing ...